HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miguel E Ortiz Selected Research

asapiprant

1/2022Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19.
4/2021Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Miguel E Ortiz Research Topics

Disease

4COVID-19
01/2022 - 10/2020
3Infections
01/2022 - 01/2021
1Weight Loss (Weight Reduction)
01/2021

Drug/Important Bio-Agent (IBA)

2EicosanoidsIBA
01/2022 - 04/2021
2asapiprantIBA
01/2022 - 04/2021
1Messenger RNA (mRNA)IBA
01/2022
1prostaglandin D2 receptorIBA
01/2022
1Prostaglandin D2IBA
01/2022
1Phospholipases A2 (Phospholipase A2)IBA
01/2022
1Phospholipases (Phospholipase)IBA
01/2022
1COVID-19 VaccinesIBA
04/2021
1VaccinesIBA
04/2021
1Prostaglandins DIBA
04/2021
1Pharmaceutical PreparationsIBA
04/2021
1Serine Proteases (Serine Protease)IBA
01/2021
1avoralstatIBA
01/2021
1AntipainIBA
01/2021
1Trypsin InhibitorsIBA
01/2021
1PCI-27483IBA
01/2021
1Angiotensin-Converting Enzyme 2IBA
10/2020
1RNA (Ribonucleic Acid)IBA
10/2020